questionText: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the UK-US Pharmaceutical deal on patient access to medicines.
answerText: The United Kingdom has secured mitigations under the United States’ ‘Most Favoured Nation’ drug pricing initiative so that we will continue to ensure access to the latest treatments. This will encourage pharmaceutical companies from around the world to pr...
heading: Drugs: USA